$AVNS
AVANOS MEDICAL, INC. Stock $avns

$avns Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000160649815000032 Filed on November 04, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q3
Revenue	-$664.0M	$389.5M	$408.5M
YoY Change	-251.12%	-4.65%	-2.62%
Cost Of Revenue	-$523.8M	$258.5M	$276.3M
YoY Change	-285.15%	-6.44%	7.09%
Gross Profit	-$140.2M	$131.0M	$132.2M
YoY Change	-189.58%	-0.91%	-18.14%
Gross Profit Margin		33.63%	32.36%
Selling, General & Admin	$49.50M	$97.20M	$111.3M
YoY Change	-60.84%	-12.67%	34.91%
% of Gross Profit		74.2%	84.19%
Research & Development	$5.100M	$10.20M	$8.500M
YoY Change	-32.0%	20.0%	-4.49%
% of Gross Profit		7.79%	6.43%
Depreciation & Amortization	$16.80M	$10.00M	$19.00M
YoY Change	-29.41%	-47.37%	90.0%
% of Gross Profit		7.63%	14.37%
Operating Expenses	-$402.7M	$107.4M	$119.8M
YoY Change	-403.92%	-10.35%	31.07%
Operating Profit	$262.5M	-$461.2M	$13.10M
YoY Change	993.75%	-3620.61%	-81.37%
Interest Expense	-$8.000M	$7.800M	$100.0K
YoY Change	35.59%	7700.0%
% of Operating Profit	-3.05%		0.76%
Other Income/Expense, Net
YoY Change
Pretax Income	$254.5M	-$469.0M	$14.00M
YoY Change	1306.08%	-3450.0%	-80.28%
Income Tax	-$85.10M	$1.500M	$21.40M
% Of Pretax Income	-33.44%		152.86%
Net Earnings	$14.50M	-$470.5M	-$7.400M
YoY Change	-704.17%	6258.11%	-115.45%
Net Earnings / Revenue		-120.8%	-1.81%
Basic Earnings Per Share		-$10.10	-$0.16
Diluted Earnings Per Share	$306.6K	-$10.10	-$0.16
COMMON SHARES
Basic Shares Outstanding	46.61M shares	46.60M shares	46.50M shares
Diluted Shares Outstanding		46.60M shares	46.50M shares

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$129.5M	$112.5M	$58.40M
YoY Change	-13.09%	92.64%
Cash & Equivalents	$129.5M	$112.5M	$58.40M
Short-Term Investments
Other Short-Term Assets	$18.60M	$25.50M	$50.80M
YoY Change	-1.59%	-49.8%
Inventory	$303.2M	$323.6M	$294.7M
Prepaid Expenses
Receivables	$224.7M	$204.4M	$192.2M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$676.0M	$666.0M	$596.1M
YoY Change	-1.11%	11.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$279.5M	$282.1M	$292.8M
YoY Change	0.61%	-3.65%
Goodwill	$678.4M	$943.4M	$1.429B
YoY Change	-52.43%	-33.98%
Intangibles	$82.60M	$89.00M	$116.3M
YoY Change	-23.73%	-23.47%
Long-Term Investments	$0.00	$0.00
YoY Change
Other Assets	$2.000M	$25.80M	$15.20M
YoY Change	-9.09%	69.74%
Total Long-Term Assets	$1.324B	$1.340B	$1.853B
YoY Change	-27.81%	-27.68%
TOTAL ASSETS
Total Short-Term Assets	$676.0M	$666.0M	$596.1M
Total Long-Term Assets	$1.324B	$1.340B	$1.853B
Total Assets	$2.000B	$2.006B	$2.449B
YoY Change	-20.56%	-18.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$163.2M	$179.1M	$118.4M
YoY Change	-3.26%	51.27%
Accrued Expenses	$152.0M	$147.7M	$148.6M
YoY Change	-17.12%	-0.61%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$10.90M
YoY Change	-100.0%	-100.0%
Long-Term Debt Due	$0.00	$0.00
YoY Change	-100.0%
Total Short-Term Liabilities	$315.2M	$326.8M	$277.9M
YoY Change	-11.46%	17.6%
LONG-TERM LIABILITIES
Long-Term Debt	$578.1M	$585.9M	$0.00
YoY Change	-7.15%
Other Long-Term Liabilities	$27.80M	$52.60M	$4.900M
YoY Change	37.62%	973.47%
Total Long-Term Liabilities	$51.60M	$52.60M	$92.50M
YoY Change	7.28%	-43.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$315.2M	$326.8M	$277.9M
Total Long-Term Liabilities	$51.60M	$52.60M	$92.50M
Total Liabilities	$944.9M	$965.3M	$370.4M
YoY Change	-7.97%	160.61%
SHAREHOLDERS EQUITY
Retained Earnings	-$419.0M	-$433.6M
YoY Change	-5839.73%
Common Stock	$500.0K	$500.0K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.000M	$1.000M
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.055B	$1.041B	$2.079B
YoY Change
Total Liabilities & Shareholders Equity	$2.000B	$2.006B	$2.449B
YoY Change	-20.56%	-18.09%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	$14.50M	-$470.5M	-$7.400M
YoY Change	-704.17%	6258.11%	-115.45%
Depreciation, Depletion And Amortization	$16.80M	$10.00M	$19.00M
YoY Change	-29.41%	-47.37%	90.0%
Cash From Operating Activities	$23.00M	$18.90M	$23.60M
YoY Change	-43.35%	-19.92%	-61.37%
INVESTING ACTIVITIES
Capital Expenditures	-$6.000M	-$19.20M	-$32.40M
YoY Change	-66.85%	-40.74%	151.16%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$100.0K	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$6.000M	-$19.10M	-$32.40M
YoY Change	-41.75%	-41.05%	151.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	200.0K	300.0K	18.40M
YoY Change	-99.68%	-98.37%	-136.08%
NET CHANGE
Cash From Operating Activities	23.00M	18.90M	23.60M
Cash From Investing Activities	-6.000M	-19.10M	-32.40M
Cash From Financing Activities	200.0K	300.0K	18.40M
Net Change In Cash	17.20M	100.0K	9.600M
YoY Change	-81.28%	-98.96%	-442.86%
FREE CASH FLOW
Cash From Operating Activities	$23.00M	$18.90M	$23.60M
Capital Expenditures	-$6.000M	-$19.20M	-$32.40M
Free Cash Flow	$29.00M	$38.10M	$56.00M
YoY Change	-50.6%	-31.96%	-24.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	hyh	Decrease Increasein Parent Companys Net Investment DecreaseIncreaseinParentCompanysNetInvestment	0	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001606498
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	46613982	shares
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	HALYARD HEALTH, INC.
CY2014Q4	hyh	Accrued Rebates AccruedRebates	82200000	USD
CY2015Q3	hyh	Accrued Rebates AccruedRebates	69300000	USD
	hyh	Decrease Increasein Parent Companys Net Investment DecreaseIncreaseinParentCompanysNetInvestment	34800000	USD
CY2014Q4	hyh	Deferred Tax Assets Netof Valuation Allowance Currentand Other Assets Current DeferredTaxAssetsNetofValuationAllowanceCurrentandOtherAssetsCurrent	18900000	USD
CY2015Q3	hyh	Deferred Tax Assets Netof Valuation Allowance Currentand Other Assets Current DeferredTaxAssetsNetofValuationAllowanceCurrentandOtherAssetsCurrent	25500000	USD
	hyh	Intercompany Activity Net IntercompanyActivityNet	0	USD
CY2014Q4	hyh	Inventories Net Lifo InventoriesNetLIFO	232200000	USD
CY2015Q3	hyh	Inventories Net Lifo InventoriesNetLIFO	268500000	USD
CY2014Q4	hyh	Inventory Finished Goods Gross Lifo InventoryFinishedGoodsGrossLIFO	157800000	USD
CY2015Q3	hyh	Inventory Finished Goods Gross Lifo InventoryFinishedGoodsGrossLIFO	182100000	USD
CY2014Q4	hyh	Inventory Finished Goods Gross Non Lifo InventoryFinishedGoodsGrossNonLIFO	37500000	USD
CY2015Q3	hyh	Inventory Finished Goods Gross Non Lifo InventoryFinishedGoodsGrossNonLIFO	42100000	USD
CY2014Q4	hyh	Inventory Gross Lifo InventoryGrossLIFO	253900000	USD
CY2015Q3	hyh	Inventory Gross Lifo InventoryGrossLIFO	284800000	USD
CY2014Q4	hyh	Inventory Gross Non Lifo InventoryGrossNonLIFO	50900000	USD
CY2015Q3	hyh	Inventory Gross Non Lifo InventoryGrossNonLIFO	55100000	USD
CY2014Q4	hyh	Inventory Net Non Lifo InventoryNetNonLIFO	50900000	USD
CY2015Q3	hyh	Inventory Net Non Lifo InventoryNetNonLIFO	55100000	USD
CY2014Q4	hyh	Inventory Raw Materials Gross Lifo InventoryRawMaterialsGrossLIFO	48400000	USD
CY2015Q3	hyh	Inventory Raw Materials Gross Lifo InventoryRawMaterialsGrossLIFO	55000000	USD
CY2014Q4	hyh	Inventory Raw Materials Gross Non Lifo InventoryRawMaterialsGrossNonLIFO	1300000	USD
CY2015Q3	hyh	Inventory Raw Materials Gross Non Lifo InventoryRawMaterialsGrossNonLIFO	700000	USD
CY2014Q4	hyh	Inventory Workin Process Gross Lifo InventoryWorkinProcessGrossLIFO	47700000	USD
CY2015Q3	hyh	Inventory Workin Process Gross Lifo InventoryWorkinProcessGrossLIFO	47700000	USD
CY2014Q4	hyh	Inventory Workin Process Gross Non Lifo InventoryWorkinProcessGrossNonLIFO	300000	USD
CY2015Q3	hyh	Inventory Workin Process Gross Non Lifo InventoryWorkinProcessGrossNonLIFO	600000	USD
	hyh	Legal Expense And Settlement Accrual LegalExpenseAndSettlementAccrual	9000000	USD
CY2014Q4	hyh	Other Inventory Supplies Gross Lifo OtherInventorySuppliesGrossLIFO	0	USD
CY2015Q3	hyh	Other Inventory Supplies Gross Lifo OtherInventorySuppliesGrossLIFO	0	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1502500000	USD
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1517900000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14000000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1000000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-42800000	USD
CY2014Q4	hyh	Other Inventory Supplies Gross Non Lifo OtherInventorySuppliesGrossNonLIFO	11800000	USD
CY2015Q3	hyh	Other Inventory Supplies Gross Non Lifo OtherInventorySuppliesGrossNonLIFO	11700000	USD
	hyh	Royalty Agreement Duration RoyaltyAgreementDuration	P24M
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	168700000	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	179100000	USD
CY2014Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	234900000	USD
CY2015Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	205700000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	233900000	USD
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	204400000	USD
CY2014Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	1600000	USD
CY2015Q3	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	1200000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	183400000	USD
CY2015Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	147700000	USD
CY2014Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	46400000	USD
CY2015Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	32500000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	290900000	USD
CY2015Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	315500000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-19100000	USD
CY2015Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1300000	USD
CY2014Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8000000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	24000000	USD
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6000000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	19000000	USD
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	200000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	200000	shares
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	41900000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2014Q4	us-gaap	Assets Assets	2527600000	USD
CY2015Q3	us-gaap	Assets Assets	2006300000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	684900000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	666000000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44100000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58400000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	149000000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	112500000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	14300000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-36500000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Debt Current DebtCurrent	3900000	USD
CY2015Q3	us-gaap	Debt Current DebtCurrent	0	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	27900000	USD
CY2015Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	28600000	USD
CY2014Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	7800000	USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46535951	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46613982	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46535951	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46613982	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	500000	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	500000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16900000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	28000000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-484400000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-464500000	USD
CY2014Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	276300000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	840600000	USD
CY2015Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	258500000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	775000000	USD
CY2015Q3	us-gaap	Deposit Liability Current DepositLiabilityCurrent	0	USD
CY2014Q3	us-gaap	Depreciation Depreciation	19000000	USD
	us-gaap	Depreciation Depreciation	37000000	USD
CY2015Q3	us-gaap	Depreciation Depreciation	10000000	USD
	us-gaap	Depreciation Depreciation	29000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	61600000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	48600000	USD
CY2014Q4	us-gaap	Disposal Group Including Discontinued Operation Long Lived Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationLongLivedAssetsNoncurrent	2600000	USD
CY2015Q3	us-gaap	Disposal Group Including Discontinued Operation Long Lived Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationLongLivedAssetsNoncurrent	0	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-10.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-9.46
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.63
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-10.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-9.46
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-200000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-3700000	USD
	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	0	USD
	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	1200000	USD
CY2014Q4	us-gaap	Equity Method Investments EquityMethodInvestments	0	USD
CY2015Q3	us-gaap	Equity Method Investments EquityMethodInvestments	0	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	222400000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	241700000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	26800000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	6300000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	7600000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	11800000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	15600000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	20900000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	324000000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	330700000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	101600000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	89000000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-3500000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	7600000	USD
CY2015Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1000000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	1426100000	USD
CY2015Q3	us-gaap	Goodwill Goodwill	943400000	USD
CY2014Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2015Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	475500000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	475500000	USD
	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-7200000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	132200000	USD
	us-gaap	Gross Profit GrossProfit	392100000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	131000000	USD
	us-gaap	Gross Profit GrossProfit	398000000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	14000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	73100000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-469000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-423000000	USD
CY2014Q3	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	0	USD
	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	0	USD
CY2015Q3	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	0	USD
	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	0	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21400000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	43600000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1500000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17800000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	7000000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	33200000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10900000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-33100000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-27500000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-37300000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9100000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	40500000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-500000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1900000	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	108300000	USD
CY2015Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	89000000	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	100000	USD
	us-gaap	Interest Expense InterestExpense	100000	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	7800000	USD
	us-gaap	Interest Expense InterestExpense	25000000	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	195300000	USD
CY2015Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	224200000	USD
CY2014Q4	us-gaap	Inventory Gross InventoryGross	304800000	USD
CY2015Q3	us-gaap	Inventory Gross InventoryGross	339900000	USD
CY2014Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	21700000	USD
CY2015Q3	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	16300000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	283100000	USD
CY2015Q3	us-gaap	Inventory Net InventoryNet	323600000	USD
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	49700000	USD
CY2015Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	55700000	USD
CY2014Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	48000000	USD
CY2015Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	48300000	USD
CY2014Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1000000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2900000	USD
CY2015Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	200000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	1036400000	USD
CY2015Q3	us-gaap	Liabilities Liabilities	965300000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2527600000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2006300000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	356000000	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	326800000	USD
CY2014Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	48100000	USD
CY2015Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	52600000	USD
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	636200000	USD
CY2015Q3	us-gaap	Long Term Debt LongTermDebt	585900000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3900000	USD
CY2015Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	632300000	USD
CY2015Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	585900000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-32400000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-50800000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-60400000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-56600000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	107300000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5100000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	74600000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-7400000	USD
	us-gaap	Net Income Loss NetIncomeLoss	29500000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-470500000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-440800000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	13100000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	70300000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-461200000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-398200000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	23600000	USD
CY2015Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	30500000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	27900000	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	25800000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent	0	USD
CY2015Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent	-100000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2015Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-200000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Before Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPortionAttributableToParent	-400000	USD
	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Before Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPortionAttributableToParent	4600000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Before Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPortionAttributableToParent	-2000000	USD
	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Before Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPortionAttributableToParent	-2300000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	-300000	USD
	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	3900000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	-1400000	USD
	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	-1600000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-9200000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-5400000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-12500000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-22300000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-9200000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-5400000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-12500000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-22300000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-9600000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-800000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-14500000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-24500000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-9500000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1500000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-13900000	USD
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	111300000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	298100000	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	97200000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	300200000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-23700000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-100000	USD
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	700000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-600000	USD
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-800000	USD
CY2014Q4	us-gaap	Other Inventory Supplies OtherInventorySupplies	11800000	USD
CY2015Q3	us-gaap	Other Inventory Supplies OtherInventorySupplies	11700000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	48100000	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	52600000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-16100000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-1800000	USD
CY2014Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	700000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2400000	USD
CY2015Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-9300000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2000000	USD
CY2014Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	18600000	USD
CY2015Q3	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	22800000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1000000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	60400000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	64400000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2015Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1900000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	3400000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	7800000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	568700000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	597600000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	277800000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	282100000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2900000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	51000000	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8500000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26100000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10200000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22500000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7300000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-433600000	USD
CY2014Q3	us-gaap	Sales Revenue Net SalesRevenueNet	408500000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1232700000	USD
CY2015Q3	us-gaap	Sales Revenue Net SalesRevenueNet	389500000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1173000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	14100000	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	210000	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	33.26
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	53000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	628000	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	611000	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1149000	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	34.94
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	40.71
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	200000	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	31.05
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	37.90
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	45.52
CY2015Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	210000	shares
CY2015Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1149000	shares
CY2015Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	200000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y8M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y10M24D
CY2015Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	33.26
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P8Y10M24D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	37000	shares
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	1491200000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	1041000000	USD
	us-gaap	Subsidiary Or Equity Method Investee Cumulative Percentage Ownership After All Transactions SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions	1
CY2014Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	23400000	USD
CY2015Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	15400000	USD
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2015Q3	us-gaap	Treasury Stock Value TreasuryStockValue	1000000	USD
CY2014Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2015Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46500000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46500000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46600000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46600000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46500000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46500000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46600000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46600000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preparation of our condensed consolidated financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting periods. Estimates are used in accounting for, among other things, distributor rebate accruals, future cash flows associated with impairment testing for goodwill and long-lived assets, loss contingencies, and deferred tax assets and potential income tax assessments. Actual results could differ from these estimates, and the effect of the change could be material to our financial statements. Changes in these estimates are recorded when known.</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We completed the required annual testing of goodwill for impairment for our Medical Devices reporting unit using the beginning of the third quarter of </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;"> as the measurement date and our analysis indicated that we had no impairment of goodwill for our Medical Devices reporting unit. However, in the first step of the goodwill impairment test, the net book value of our S&IP reporting unit exceeded its fair value. Accordingly, we are in the process of completing the second step of the goodwill impairment test to determine the final impairment amount. See </font><font style="font-family:inherit;font-size:10pt;">Note 2</font><font style="font-family:inherit;font-size:10pt;">, “Annual Goodwill Impairment Test” for further details.</font></div></div>

Files In Submission

Name	View Source	Status
0001606498-15-000032-index-headers.html	Edgar Link	pending
0001606498-15-000032-index.html	Edgar Link	pending
0001606498-15-000032.txt	Edgar Link	pending
0001606498-15-000032-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
halyardhealthlogoa02.jpg	Edgar Link	pending
hyh-20150930.xml	Edgar Link	completed
hyh-20150930.xsd	Edgar Link	pending
hyh-20150930_cal.xml	Edgar Link	unprocessable
hyh-20150930_def.xml	Edgar Link	unprocessable
hyh-20150930_lab.xml	Edgar Link	unprocessable
hyh-20150930_pre.xml	Edgar Link	unprocessable
hyh3q2015form10q.htm	Edgar Link	pending
hyh3q2015form10qex31a.htm	Edgar Link	pending
hyh3q2015form10qex31b.htm	Edgar Link	pending
hyh3q2015form10qex32a.htm	Edgar Link	pending
hyh3q2015form10qex32b.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AVNS
AVANOS MEDICAL, INC. Stock $avns

2015 Q4 Form 10-Q Financial Statement

#000160649815000032 Filed on November 04, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVNS AVANOS MEDICAL, INC. Stock $avns

2015 Q4 Form 10-Q Financial Statement

#000160649815000032 Filed on November 04, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVNS
AVANOS MEDICAL, INC. Stock $avns